SEARCH

SEARCH BY CITATION

References

  • 1
    Carman W, Thomas H, Domingo E. Viral genetic variation: hepatitis B virus as a clinical example. Lancet 1993; 341: 349353.
  • 2
    Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; 2: 588591.
  • 3
    Brunette MR, Stemler M, Schodel F, Will H, Ottobrelli A, Rizzetto M, Verme G, et al. Identification of HBV variants which cannot produce precore derived HBeAg and may be responsible for severe hepatitis. Ital J Gastroenterol 1989; 21: 151154.
  • 4
    Bonino F, Rosina F, Rizzetto M, Rizzi R, Chiaberge E, Tardanico R, Callea F, et al. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology 1986; 90: 12681273.
  • 5
    Brunetto MR, Oliveri F, Rocca G, Criscuolo D, Chiaberge E, Capalbo M, David E, et al. Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen. Hepatology 1989; 10: 198202.
  • 6
    de Franchis R, Meucci G, Vecchi M, Tatarella M, Colombo M, Del Ninno E, Rumi MG, et al. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 1993; 118: 191194.
  • 7
    Liaw Y-F, Tai D-I, Chu C-M, Chen T.-J. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 1988; 8: 493496.
  • 8
    Fattovich G, Brollo L, Giustina G, Noventa F, Pontisso P, Alberti A, Realdi G, et al. Natural history and prognostic factors for chronic hepatitis type B. Gut 1991; 32: 294298.
  • 9
    Fattovich G, Farci P, Rugge M, Brollo L, Mandas A, Pontisso P, Giustina G, et al. A randomized controlled trial of lymphoblastoid interferonalfa in patients with chronic hepatitis B lacking HBeAg. Hepatology 1992; 15: 584589.
  • 10
    Pastore G, Santantonio T, Milella M, Monno L, Mariano N, Moschetta R, Pollice L. Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum: response to a 6-month course of lymphoblastoid interferon. J Hepatol 1992; 14: 221225.
  • 11
    Hadziyannis S, Bramon T, Makris A, Moussoulis G, Zignego L, Papaioannou C. Interferon alfa-2b treatment for HBeAg negative/serum HBV-DNA positive chronic active hepatitis type B. J Hepatol 1990; 11 (suppl): 133S136S.
  • 12
    Krogsgaard K, Bindslev N, Christensen E, Craxì A, Schlichting P, Schalm S, Carreno V, et al. The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. J Hepatol 1994: 21; 646655.
  • 13
    Brunetto MR, Cerenzia M Torrani, Oliveri F, Piantino P, Randone A, Calvo PL, Manzini P, et al. Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc. J Hepatol 1993: 19; 431436.
  • 14
    Scotto J, Hadchouel M, Hery C, Yvart J, Tiollais P, Brechot C. Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: comparison with results for other viral markers. Hepatology 1983; 2: 279284.
  • 15
    Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 1994; 93: 230239.
  • 16
    Lampertico P, Manzin A, Rumi MG, Paolucci S, Del Ninno E, Clementi M, Colombo M. Hepatitis B virus precore mutants in HBeAg carriers with chronic hepatitis treated with interferon. J Viral Hepat 1995; 2: 251256.
  • 17
    Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 15131520.
  • 18
    Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431435.
  • 19
    Popper H. Changing concepts of the evolution of chronic hepatitis and the role of piecemeal necrosis. Hepatology 1983; 3: 758762.
  • 20
    Lau JYN, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet 1993; 342: 13351340.
  • 21
    Lau JY, Bird GL, Naoumov NV, Williams R. Hepatic HLA antigen display in chronic hepatitis B virus infection. Relation to hepatic expression of HBV genome/gene products and liver histology. Dig Dis Sci 1993; 38: 888895.
  • 22
    Fattovich G, Giustina G, Favarato S, Ruol A, and Investigators of the Italian Association for the Study of the Liver. A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 1996; 24: 3847.
  • 23
    Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333: 16571661.
  • 24
    Main J, Brown JL, Howells C, Galassini L, Crossey M, Karayiannis P, Georgiou P, et al. A double-blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection. J Viral Hepat 1996; 3: 211215.